Abstract
Study of the relationship between the chemical structure and the biological activity of hormones has long been recognized as a valid approach to the elucidation of that initial chemical interplay between hormone and responsive cell which constitutes the primary step in hormone action. It would of course be desirable also to know the sequence and detailed nature of all other events leading to and including the final effector process for each of the final physiological effects of a given hormone on each of its target tissues. However, a thorough understanding of even the initial event in hormone action requires that structure-activity analysis be carried to the conformational level, and, indeed, work directed to this goal is under way (Walter et al. 1971). Nevertheless, the approach to the study of peptide hormone-receptor interaction at the three-dimensional (topochemical) level of structure must be regarded as derivative from antecedent classical structure-activity studies—for it is the primary structure of both hormone and receptor that determines the conformation of the active hormone-receptor complex.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bär, H. P., Hechter, O., Schwartz, I. L., and Walter, R., 1970, Proc. Natl. Acad. Sci 67:7.
Berankova-Ksandrova, Z., Bisset, G. W., Jost, K., Krejci, I., Pliska, V., Rudinger, J., Rychlik, I., and Sorm, F., 1966, Brit. J. Pharmacol. Chemotherap 26:615.
Berde, B., and Boissonnas, R. A., 1966, Synthetic analogues and homologues of the posterior pituitary hormones. in “The Pituitary Gland,” Vol. 3, p.624.
Berde, B., Boissonnas, R. A., Huguenin, R. L., and Sturmer, E., 1964, Experientia (G. W. Harris and B. T. Donovan, eds.), 20:42. Butterworth. London.
Berde, B., and Boissonnas, R. A., 1968, Basic pharmacological properties of synthetic analogues and homologues of the neurohypophysical hormones, in “Neurohypophysial Hormones and Similar Polypeptides.” Vol. 23 of “Handbook of Experimental Pharmacology,” (B. Berde, eds.). p. 802, Springer-Verlag, New York.
Berde, B., and Konzett, H., 1960, Med. Exper 2:317.
Bespalova, Zh. D., Martynov, V. F., and Titov, M. I., 1968, Zh. Obshch. Khim 38:1684.
Boissonnas, R. A., and Guttman, St., 1960. Heir. Chim. Acta 43:190.
Boissonnas, R. A., Guttman, St., Jaquenous, P. A., and Waller, J. P., 1956, Helv. Chim. Acta 39:1421.
Boissonnas, R. A., Guttman, St., and Konzett, H., 1961, Experientia 17:377.
Branda, L. A., and Du Vigneaud, V., 1966, J. Med. Chem 9:169.
Celis, M., Taleisnik, S., Schwartz, I. L., and Walter, R., 1971a, Biophys. J 11:98a.
Celis, M., Taleisnik, S., and Walter, R., 1971b, Proc. Natl. Acad. Sci 68:1428.
Chan, W. Y., and du Vigneaud. V., 1970. J. Pharmacol. Exptl. Therap 174:541.
Chan, W. Y., and Kelley, N., 1967, J. Pharmacol. Expt/. Therap 156:150.
Chimiak, A., and Rudinger, J., 1965. Coll. Czech. Chem. Commun 39:2592.
Chiu, P. J. S., and Sawyer, W H., 1970, Am. J. Physiol 218:838.
Dousa, T., Hechter, O., Walter, R., and Schwartz, I. L., 1970a, Physiologist 13:182.
Dousa, T., Hechter, O., Walter, R., and Schwartz, L L., 1970b, Science 167:1134.
Dousa, T., Hechter, O., Schwartz, I. L., and Walter, R., 1971, Proc. Natl. Acad. Sci 68:1693.
Draper, W. B., 1927, Am. J. Phvsiol 80:90.
Dudley, H. W., 1923, J. Pharmacol 21:103.
du Vigneaud. V., 1956a, Harecy Lectures 50:1.
du Vigneaud, V., 1956bScience 123:967.
du Vigneaud, V., 1964. Proc. Robert.4. Welch Found. Conf. Chem. Res 8:133.
du Vigneaud, V., Ressler, C., Swan, J. M., Roberts, C. W., Katsoyannis, P. G., and Gordon, S., 1953, J. Am. Chem. Soc 75:4879
du Vigneaud, V., Denning, G. S., Jr., Draborek, S., and Chan, W. Y., 1964, J. Biol. Chem 238:472.
du Vigneaud, V., Flouret, G., and Walter, R., 1966, J. Biol. Chem 241:2093.
Eggena, P., Walter, R., and Schwartz, I. L., 1969, Stimulus-effect relationship in the anti-diuretic action of neurohypophyseal peptides and prostaglandin E, “Proceedings of the Fourth, International Congress of Nephrology, Stockholm,” p. 257.
Eggena, P., Schwartz, I. L., and Walter, R., 1970, J. Gen. Physiol 56:250.
Eisler, K., Rudinger, J., and Sorm, F., 1966, Coll. Czech. Chem. Commun 31:4563.
Havran, R. T., Schwartz, I. L., and Walter, R., 1969, J. Am. Chem. Soc 91:1836.
Hechter, O., and Braun, T., 1971, Peptide hormone—receptor interaction, “Structure—Activity Relationships of Protein and Polypeptide Hormones,” Part I (M. Margoulies and F. C. Greenwood, eds.), p. 212. Excerpta Medica International Congress Series No. 241, Exerpta Medica Foundations. Amsterdam.
Hermann, P., and Zaoral, M., 1965. Coll. Czech. Chem. Commun 30:2817.
Hruby, V. J., Flouret, G., and du Vigneaud, V., 1969. J. Biol. Chem 244:3890.
Hruby, V. J., du Vigneaud. V., and Chan, W. Y., 1970, J. Med. Chem 13:185.
Huguenin, R. L., and Boissonnas, R. A., 1966, HeIv. Chim. Acta. 49:695.
Jaquenoud, P. A., and Boissonnas, R. A., 1961, Hely. Chim. Acta. 44:133.
Jaquenoud, P. A., and Boissonnas, R. A., 1962a, Heiv. Chico. Acta. 45:1601.
Jaquenoud, P. A., and Boissonnas, R. A., 1962b, Heiv. Chim. Acta. 45:1462.
Kamm, O., Aldrich, T. B., Grate, I. W., Rowe, L. W and Bugbee, E. P., 1928, J. Am. Chem. Soc 50:573.
Jarvis, D., and du Vigneaud, V., 1964, Science 143:545.
Jost, K., and Rudinger, J., 1967, Coll. Czech. Chem. Commun 32:1229.
Kamm, O., Aldrich, T. B., Grate, I. W., Rowe, L. W and Bugbee, E. P., 1928, J. Am. Chem. Soc 50:573.
Katzoyannis, P. G., 1957, J. Am. Chem. Soc 79:109.
Katsoyannis, P. G., and du Vigneaud, V., 1958. J. Biol. Chem 233:1352.
Kimbrough, R. D., Jr., Cash, W. D., Branda, L. A., Chan, W. Y., and du Vigneaud, V., 1963, J. Biol. Chem 238:1411.
Kirchberger, M., Walter, R., Schwartz, I. L., Bar, H. P. and Hechter, O., 1971, Unpublished data.
Krejci, I., and Polacek, I 1968. Europ. J. Pharmacol 2:393.
Livermore, A. H., and du Vigneaud, V., 1949, J. Biol. Chem 180:365.
Manning, M., Coy, E., and Sawyer, W. H., 1970, Biochemistry 9:3925.
Morel, F., and Bastide, F., 1964, Relationship between the structure of several analogues of oxytocin and their “natriferic” activity in vitro, in “Oxytocin, Vasopressin and Their Structural Analogues, Proceedings of the Second International Pharmacology Meeting,” Vol. 10 (J. Rudinger, eds.), p. 47. Pergamon Press, Oxford.
Nesvadba, A., Honzl, J., and Rudinger, J., 1963, Coll. Czech. Chem. Commun 28:1691.
Pickering, B. T., 1970, Aspects of the relationship between the chemical structure and biological activity of the neurohypophyseal hormones and their synthetic analogues, “Pharma-cology of the Endocrine System and Related Drugs: The Neurohypophysis,” Vol. I (H. Heller and B T. Pickering, eds.), p. 81, Pergamon Press, Oxford.
Rasmussen, H Schwartz, I. L., Young, R., and Marc-Aurele, J., 1963, J. Gen. Physiol 46:1171.
Ressler, C., 1956, Proc. Soc. Exptl. Biol. Med 92:725.
Ressler, C., and du Vigneaud. V., 1957, J. Am. Chem. Soc 79:4511.
Rudinger, J., 1969, Neurohypophyseal peptides and synthetic analogues: Structure and hormonal action, “Progress in Endocrinology, Proceedings of the Third International Congress of Endocrinology” (C. Gual, eds.). p. 419, Excerpta Medica International Congress Series No. 184, Excerpta Medica Foundation, Amsterdam.
Rudinger, J., and Jost. K., 1964a, Synthetic analogues of oxytocin and vasopressin: Structural relations, “Oxytocin, Vasopressin and Their Structural Analogues, Proceedings of the Second International Pharmacology Meeting, Vol. 10 (J. Rudinger, eds.), p. 3, Pergamon Press, Oxford.
Rudinger, J., and Jost, K., 1964b, Experientia 20570.
Rudinger, J., and Krejci, I 1962, Experientia 18585.
Rudinger, J., and Krejci, 1., 1968. Antagonists of the neurohypophysial hormones, “Neurohypophysial Hormones and Similar Polypeptides,” Vol. 23 of “Handbook of Experimental Pharmacology,” (B. Berde, eds.), p. 748, Springer-Verlag, New York.
Rudinger, J., Honzl, J., and Zaoral, M., 1956, Coll. Czech. Chem. Commun 21770.
Rychlik, I 1964, Inactivation of oxytocin and vasopressin by tissue enzymes: A basis for the design of analogues, “Oxytocin, Vasopressin and Their Structural Analogues, Proceedings of the Second International Pharmacology Meeting,” Vol. 10 (J. Rudinger, eds.), p. 153, Pergamon Press, Oxford.
Sawyer, W. H., 1965. Endocrinology 5:427.
Schlapp, W., 1925. Quart. J. Exptl. Physiol 15327.
Schwartz, I. L., 1955, Adiuretin, in “Mechanisms of Hormone Action, A NATO Advanced Study Institute” (P. Karlson, eds.), p. 121, Academic Press, New York.
Schwartz, I. L., 1971, Structure—activity relationships as a tool for the analysis of sequential events in the action of neurohypophyseal hormones on membrane permeability, “Structure—Activity Relationships of Protein and Polypeptide Hormones,” Part I (M. Margoulies and F. C. Greenwood, eds.), p. 31, Excerpta Medica International Congress Series No. 241, Excerpta Medica Foundation, Amsterdam.
Schwartz, I. L., and Hechter, O., 1966, Insulin structure and function: Reflections on the present state of the problem, “International Symposium on Insulin” (P. G. Katsoyannis and I. L. Schwartz, eds.), Am. J. Med 40765.
Schwartz, I. L., and Livingston, L. M., 1964, Cellular and molecular aspects of the antidiuretic action of vasopressins and related peptides, “Vitamins and Hormones,” Vol. 22 (I. G. Wool, eds.), p. 261, Academic Press, New York.
Schwartz, I. L., Rasmussen, H., Marc-Aurele, J., and Christman, D., 1964a, Molecular phenomena related to the mechanism of action of vasopressin on membrane permeability, “The Biochemical Aspects of Hormone Action” (A. B. Eisenstein, eds.), p. 66, Little, Brown. Boston.
Schwartz, I. L., Rasmussen, H., Livingston, L. M., and Marc-Aurele, J., 1964b, Neurohypophyseal hormone—receptor interactions, “Oxytocin, Vasopressin and Their Structural Analogues, Proceedings of the Second International Pharmacology Meeting” (J. Rudinger, eds.) p. 125, Pergamon Press, Oxford.
Schwartz, I. L., Rasmussen, H., and Rudinger, J., 1964e, Proc. Natl. Acad. Sci 521044.
Smyth, D. G., 1967, J. Biol. Chem 2421579.
Smyth, D. G., 1970, Biochim. Biophys. Acta 200395.
Studer, R. O., and Cash, W. D., 1963, J. Biol. Chem 238657.
Urry, D. W., and Walter, R 1971, Proc. Natl. Acad. Sci 68956.
Van Dyke, H. B., Sawyer, W. H., and Overweg, N. I. A., 1963, Endocrinology 73637.
Walter, R 1971, Conformations of oxytocin and lysine vasopressin and their relationships to the biology of neurohypophyseal hormones, “Structure—Activity Relationships of Protein and Polypeptide Hormones,” Part 1 (M. Margoulies and F. C. Greenwood, eds.), p. 181, Excerpta Medica International Congress Series No. 241, Excerpta Medica Foundation, Amsterdam.
Walter, R and Schwartz, I. L., 1966, J. Biol. Chem 241550.
Walter, R Rudinger, J., and Schwartz, I. L., 1967, Am. J. Med 42:653.
Walter, R Dubois, B. M., and Schwartz, I. L., 1968, Endocrinology 83:979.
Walter, R Dubois, B. M., Eggena, P., and Schwartz, I. L., 1969, Experientia 25:33.
Walter, R Schwartz, I. L., Darnell, H., and Urry, D. W., 1971, Proc. Natl. Acad. Sci 68:1355.
Yamanaka, T., Hase, S., Sakakibara, S., Schwartz, I L., Dubois, B. M., and Walter, R 1970, Mol. Pharmacol 6:474.
Zaoral, M., 1965, Coll. Czech. Chem. Commun 30:1853.
Zaoral, M., Kolc, J., and Sorm, F., 1967a, Coll. Czech. Chem. Commun 32:1242.
Zaoral, M., Kole, J., and Sorm, F., 1967b, Coll. Czech. Chem. Commun 32:1250.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1973 Plenum Press, New York
About this chapter
Cite this chapter
Schwartz, I.L. (1973). Neurohypophyseal Hormones: Old and New Slants on the Relationship of Chemical Structure to Biological Activity. In: Katsoyannis, P.G. (eds) The Chemistry of Polypeptides. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-4571-8_14
Download citation
DOI: https://doi.org/10.1007/978-1-4613-4571-8_14
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-4573-2
Online ISBN: 978-1-4613-4571-8
eBook Packages: Springer Book Archive